With the development of gene expression profile technology, LMO2 arose as an important gene defining the germinal center B-cell (GCB) molecular subgroup of DLBCL, as well as a relevant prognostic marker in DLBCL [11,12,13]. This evidence concerns the gene LMO2 and diffuse large B-cell lymphoma.